Clinical Study: Phytoproflex® as a Supportive Therapy for Knee Osteoarthritis

Clinical Study: Phytoproflex® as a Supportive Therapy for Knee Osteoarthritis

Knee osteoarthritis (OA) is among the most common causes of chronic joint pain and reduced mobility worldwide. While exercise, physiotherapy, weight management, and medications remain the foundation of treatment, researchers continue to investigate complementary therapies that may improve symptoms and quality of life.

A clinical registry published in Minerva Medica evaluated Phytoproflex®, a botanical supplement formulated with boswellic acid, curcumin, and valeric acid, as an adjunct to conventional osteoarthritis management.

Study Reference

Belcaro G, Dugall M, Luzzi R, et al. Phytoproflex®: supplementary management of osteoarthrosis: a supplement registry. Minerva Med. 2018;109(2):88–94.

PMID: 29534559

DOI: 10.23736/S0026-4806.17.05460-X

Why This Study Matters

Inflammation and oxidative stress contribute significantly to pain, stiffness, and functional decline in knee osteoarthritis. Plant-derived compounds such as curcumin and boswellic acid have demonstrated anti-inflammatory and antioxidant properties in laboratory and clinical research.

The purpose of this registry was to determine whether adding Phytoproflex® to standard osteoarthritis care could improve clinical outcomes without compromising safety.

Study Design

Participants continued receiving their usual treatment for osteoarthritis. Among them, 24 patients additionally received Phytoproflex® throughout the four-week study period.

Supplement Composition

The Phytoproflex® formulation evaluated in this study contained:

• Boswellic Acid (90%)
• Curcumin (20%)
• Valeric Acid (0.8%)

These botanical ingredients were selected because of their potential anti-inflammatory, antioxidant, and pain-modulating effects.

Outcomes Evaluated

Researchers assessed multiple clinical outcomes throughout the registry, including:

• Knee pain intensity
• Functional capacity
• Walking performance
• Pain-free walking distance
• Karnofsky Performance Scale
• Oxidative stress levels
• Use of rescue pain medication
• Overall safety and tolerability

Key Findings

Significant Reduction in Pain

Patients receiving Phytoproflex® experienced statistically significant reductions in knee pain after four weeks compared with baseline measurements.

Improved Daily Function

Functional ability improved significantly, with higher Karnofsky Performance Scale scores indicating greater independence during normal daily activities.

Increased Pain-Free Walking Distance

Patients taking the supplement demonstrated greater improvements in pain-free walking distance than those receiving standard care alone.

Reduced Need for Rescue Medication

Fewer participants in the Phytoproflex® group required additional pain-relieving medication during the study period.

Lower Oxidative Stress

Oxidative stress markers decreased during the study, suggesting reduced biological stress associated with osteoarthritis.

Good Safety Profile

No significant safety concerns or tolerability issues were reported among patients receiving the supplement.

Summary of Results

Authors' Conclusion

The investigators concluded that Phytoproflex® appeared to be a safe and effective supplementary therapy when used alongside standard management for knee osteoarthritis.

Patients receiving the supplement demonstrated improvements in pain, walking ability, and physical function while requiring fewer rescue medications.

Because this investigation was an observational registry, the findings should be interpreted as supportive preliminary evidence. Larger randomized controlled clinical trials are needed to further validate these results.

Clinical Perspective

Natural compounds such as curcumin and boswellic acid continue to receive growing attention for their role in managing chronic inflammatory conditions.

Although nutritional supplements should not replace evidence-based medical care, they may provide additional benefits for appropriately selected patients when integrated into a comprehensive treatment plan under medical supervision.

Study Highlights

• Published in Minerva Medica (2018)
• Indexed in PubMed (PMID: 29534559)
• Included 56 patients with knee osteoarthritis
• Four-week observational clinical registry
• Demonstrated improvements in pain and physical function
• Reduced need for rescue pain medication
• Reported good safety and tolerability

Limitations

While encouraging, several limitations should be considered:

• Small sample size
• Observational design rather than randomized controlled trial
• Short follow-up period (4 weeks)
• Additional large-scale clinical studies are warranted

Citation

Belcaro G, Dugall M, Luzzi R, Hosoi M, Ledda A, Feragalli B, Hu S, Ganguly A, Eggenhoffner R, Corti A, Giacomelli L.

Phytoproflex®: supplementary management of osteoarthrosis: a supplement registry.

Minerva Med.

2018 Apr;109(2):88–94.

DOI: 10.23736/S0026-4806.17.05460-X

PMID: 29534559

Read the Original Publication

• PubMed: https://pubmed.ncbi.nlm.nih.gov/29534559/
• DOI: https://doi.org/10.23736/S0026-4806.17.05460-X

Disclaimer: This article provides an independent summary of a published clinical study for educational purposes. It is not a substitute for professional medical advice, diagnosis, or treatment. The original publication should be consulted for complete methodology, statistical analysis, and study details.